Typicality: | 0.504 |
Saliency: | 0.466 |
with use for undefined durations | 7 | other |
with approvals for continuous administration | 6 | other |
to this day | 6 | temporal |
drug → remain on → the market | 79 |
drug → stay on → the market | 20 |
negative | neutral | positive |
0.376 | 0.523 | 0.101 |
Raw frequency | 99 |
Normalized frequency | 0.466 |
Modifier score | 0.670 |
Perplexity | 31.233 |